SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 958.74 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 126.47 |
Book Value / Share | 2.00 |
Price / Book | n/a |
NCAV ($M) | 84.96 |
NCAV / Share | 1.34 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.74 |
Return on Assets (ROA) | -0.54 |
Return on Equity (ROE) | -2.20 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.04 |
Current Ratio | 3.04 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 242.99 |
Assets | 284.49 |
Liabilities | 158.02 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
AAGH – America Great Health | ABCZF – Abcam Limited |
ABMC – American Bio Medica Corporation |
Financial data and stock pages provided by
Fintel.io